Species

Swine

Our microencapsulation technology empowered the delivery and the slow-release of active ingredients to the intestine of swine, bypassing the gastric environment. Our scientific research demonstrated that it is possible to maximize performance by lowering the concentration of the active compounds.

AviPremium®

AviPremium® is a complete range of products based on tributyrin, a triglyceride of butyric acid that promote the intestinal mucosa trophism.

INNOVANT

AviPremium® products are based on tributyrin, a triacylglycerol of butyric acid (EU Reg. 1831/2003; FDA 21 CFR 184.1903).
Tributyrin is the most concentrated derivate of butyric acid on the market. The tributyrin in it is more stable and has superior organoleptic characteristics than butyric acid. AviPremium® products are an alternative to Na-butyrate. In AviPremium®, the butyric acid from tributyrin is chemically protected and delivered where butyric acid can be effective. The esterification with glycerol allows the butyric acid to be released in the intestine due to the action of pancreatic lipases. The microencapsulation of it allows further advantages and efficacy at the intestinal level.

UNIQUE PRODUCTS

The full range of products is composed of:

AviPremium®L based on liquid tributyrin (85% butyric acid).

AviPremium®D, a concentrated source of tributyrin in powder form (55% butyric acid).

AviPremium®S and AviPremium®P where the tributyrin is microencapsulated within a vegetable lipid matrix according to the digestive characteristics of swine and poultry respectively (25% butyric acid).

Latest articles from the Press Room

  • A microencapsulated blend of botanicals supports weaning piglets during a lipopolysaccharide challenge by modulating liver inflammation and intestinal integrity

    Bonetti et al. (2024). J. Anim. Sci., 102, skae277
  • In vitro and in vivo evaluation of L–Lysine solid lipid microcapsules for swine

    Bonnici et al. (2024). 75th EAAP Annual Meeting 2024, 467
  • Effect of a botanical-based feed additive in vitro on cultured enterocytes and in vivo on weaned piglets challenged with F4+ enterotoxigenic Escherichia coli

    Bonetti et al. (2024). 75th EAAP Annual Meeting 2024, 468